剖析tRNA片段tRF3E-核素相互作用:对乳腺癌的影响
Maurizio Falconi1, Junbiao Wang1, Andrea Costamagna2
1School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
Biomolecules
|July 29, 2025
概括
这项研究揭示了tRNA片段 (tRF3E) 如何在乳腺癌细胞中结合核素 (NCL). 破坏这种相互作用会损害tRF3E的瘤抑制能力,突显了NCL向治疗的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- RNA生物学的RNA生物学
背景情况:
- 核素 (NCL) 是一种关键的RNA结合蛋白,涉及到癌症,特别是乳腺癌.
- 虽然NCL失调使其成为一个有前途的治疗标,但其RNA相互作用的了解很少.
- 像tRF3E这样的瘤抑制tRNA片段 (tRFs) 可以与NCL相互作用.
研究的目的:
- 阐明核素 (NCL) 与瘤抑制器tRNA片段tRF3E.之间的相互作用的分子机制.
- 研究NCL-RNA结合合作性在tRF3E抗瘤功能中的作用.
- 评估tRF3E作为乳腺癌潜在的NCL向治疗剂.
主要方法:
- 电泳运动移位试验 (EMSA) 用于研究RNA与蛋白质的结合.
- 在基对接分析以建模tRF3E-NCL复合体.
- 在MCF7乳腺癌细胞中进行功能性检测,以评估tRF3E的生物活性.
主要成果:
- NCL通过其RNA结合域 (RBD) 同时结合两个tRF3E分子,形成一个稳定的复合体.
- 一种突变的tRF3E (M19-24) 破坏了这种合作结合,只与NCL的RBDs的一个子集相互作用.
- 野生型tRF3E显著抑制乳腺癌细胞的增殖和殖民地形成,而M19-24突变体失去了这一功能.
结论:
- NCL和tRF3E之间的合作结合对于tRF3E在乳腺癌中的瘤抑制活性至关重要.
- 了解NCL-tRF3E相互作用动态为开发新型NCL向治疗提供了基础.
- tRF3E作为乳腺癌治疗的潜在生物药物候选人显示出希望.
相关概念视频
02:55The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K